Tempus AI, Inc. , a technology company leading the adoption of AI to advance precision medicine, today announced that eight abstracts have been accepted for presentation at the 2026 ASCO® ...
The immune response against cancer is tightly regulated through a set of stimulatory and inhibitory molecules expressed by cancer cells, stromal cells (including APCs) and haematopoietic cells in the ...
AI Foundation Model for Tumor and Immune Biology to Guide Precision Patient Selection for Novel Bifunctional OTP-01 BostonGene, the developer of the leading AI foundation model for tumor and immune ...
BostonGene, the developer of the leading AI foundation model for tumor and immune biology, today announced a strategic collaboration with Ottimo Pharma Limited ("Ottimo"), an innovative, ...
Morning Overview on MSN
Why cancer returns years later, and how we can stop it
Cancer’s cruelest trick is its ability to disappear, only to reappear years later in a new organ or a familiar scar. The fear ...
The field of cancer immunology has witnessed dramatic progress with the advent of immunotherapies targeting the tumor immune microenvironment (TIME).
Researchers are targeting dormant tumour cells that might explain why some cancers reappear long after successful treatment.
Morning Overview on MSN
Baldness cure update: What studies now suggest
Hair loss has always been emotionally loaded, but the science behind it is becoming unusually exciting. A wave of new drugs, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback